Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands, March 2020 to August 2022
ConclusionWe observed no substantial changes in HRMO prevalence in hospitalised patients during the COVID-19 pandemic.
Source: Eurosurveillance - Category: Infectious Diseases Authors: Wieke Altorf-van der Kuil, Cornelia CH Wielders, Romy D Zwittink, Sabine C de Greeff, Dave A. Dongelmans, Ed J Kuijper, Daan W Notermans, Annelot F Schoffelen and on behalf of the study collaborators ISIS-AR study group Source Type: research
More News: Antimicrobial Resistance | COVID-19 | Infectious Diseases | Intensive Care | Microbiology | Multidrug Resistance | Netherlands Health | Pandemics | Study